Related Experiment Video
Updated: Feb 17, 2026

Study of In Vivo Glucose Metabolism in High-fat Diet-fed Mice Using Oral Glucose Tolerance Test OGTT and Insulin Tolerance Test ITT
Published on: January 7, 2018
COVID-19 Impact on Lipid Profile and Metabolome in Patients with Type 2 Diabetes Mellitus: Mini-Review
Karolina Pawłuszkiewicz1, Anita Maria Faltus1, Gabriela Augustynowicz2
1Faculty of Medicine, Wroclaw Medical University, Wroclaw Medical University, Wroclaw, Poland.
Aim:
This review aims to explore the pathophysiological mechanisms by which SARS-- CoV-2 affects lipid metabolism and the metabolome in patients with Type 2 Diabetes Mellitus (T2DM). It compares these alterations with those observed in non-diabetic individuals and proposes strategies to mitigate potential long-term metabolic complications.
Methods:
A narrative review was conducted using PubMed, Scopus, and Google Scholar to identify studies published between 2004 and 2025 concerning adult T2DM patients during or after COVID-19 infection. The analysis focused on lipid profiles, including total cholesterol, high-density lipoprotein (HDL), low-density lipoprotein (LDL), and triglycerides, along with hemoglobin A1C levels and COVID-19 severity. Search terms included: (Post-COVID-19) AND (Diabetes Mellitus Type 2), ((Post-COVID-19) AND (Diabetes Mellitus Type 2)) AND (Lipid Profile), ((- COVID-19) AND (Lipid Profile)) AND (Diabetes Mellitus Type 2), (Post-COVID-19) AND (Lipid Metabolism), (COVID-19) AND (Lipid Metabolism), (Post-COVID-19) AND (Metabolome), (COVID-19) AND (Metabolome).
Results:
Post-COVID-19, patients with T2DM exhibit persistent disturbances in lipid metabolism and broader metabolic pathways. SARS-CoV-2 infection amplifies metabolic dysregulation, leading to decreased levels of total cholesterol, HDL, and LDL, while triglyceride levels remain variable. Mechanistically, the virus disrupts lipid homeostasis by upregulating genes such as CD36 and peroxisome proliferator-activated receptor gamma (PPAR-γ) and by altering amino acid metabolism, particularly within the tryptophan-kynurenine and glutamine pathways.
Discussion:
Enhanced oxidative stress and lipid peroxidation contribute to systemic inflammation and endothelial dysfunction. Furthermore, glycemic control worsens due to increased insulin resistance and pancreatic interactions involving angiotensin-converting enzyme 2 (ACE2).
Conclusion:
COVID-19 significantly alters lipid metabolism and the metabolomic profile in individuals with T2DM. Longitudinal studies are warranted to clarify the duration and clinical impact of these changes and to develop personalized therapeutic strategies for this high-risk population.
Insights
COVID-19 significantly disrupts lipid metabolism and the metabolome in patients with Type 2 Diabetes Mellitus (T2DM). These changes worsen glycemic control and increase oxidative stress, requiring further study for targeted therapies.
Area of Science:
- Endocrinology and Metabolism
- Infectious Diseases
- Molecular Biology
Background:
- Type 2 Diabetes Mellitus (T2DM) is a metabolic disorder characterized by insulin resistance and impaired glucose regulation.
- COVID-19, caused by SARS-CoV-2, has been associated with diverse clinical manifestations, including metabolic disturbances.
- The interaction between SARS-CoV-2 infection and T2DM pathophysiology remains incompletely understood, particularly concerning lipid metabolism.
Purpose of the Study:
- To elucidate the pathophysiological mechanisms linking SARS-CoV-2 infection to altered lipid metabolism and metabolomic profiles in T2DM patients.
- To compare metabolic alterations in T2DM patients post-COVID-19 with non-diabetic individuals.
- To propose strategies for mitigating long-term metabolic complications in this vulnerable population.
Main Methods:
- A comprehensive narrative review of studies published between 2004 and 2025 was conducted.
- Databases searched included PubMed, Scopus, and Google Scholar.
- The review focused on lipid profiles (total cholesterol, HDL, LDL, triglycerides), HbA1c, and COVID-19 severity in adult T2DM patients.
Main Results:
- Post-COVID-19, T2DM patients exhibit persistent dysregulation of lipid metabolism and broader metabolic pathways.
- SARS-CoV-2 infection exacerbates metabolic dysfunction, decreasing total cholesterol, HDL, and LDL, with variable triglyceride levels.
- Mechanisms include altered gene expression (CD36, PPAR-γ), disrupted amino acid metabolism (tryptophan-kynurenine, glutamine), increased oxidative stress, inflammation, endothelial dysfunction, and worsened glycemic control via insulin resistance and ACE2 interactions.
Conclusions:
- COVID-19 significantly impacts lipid metabolism and metabolomic profiles in individuals with T2DM.
- Further longitudinal studies are essential to determine the duration and clinical significance of these metabolic alterations.
- Personalized therapeutic strategies are needed for high-risk T2DM patients affected by COVID-19.
Related Concept Videos
Diabetes Mellitus: Type 2 and Gestational
Carbohydrate Metabolism
Starch accounts for approximately 60% of the carbohydrates consumed by humans. Since amylase enzymes cannot function in the stomach's acidic environment, starch can only be digested in the mouth and small intestine. Simple sugars are found naturally in milk and fruits in...
Overview of Carbohydrate Metabolism
Glucose transport into cells is facilitated by a family of transport proteins called GLUT (Glucose Transporters). GLUT4 is the primary glucose transporter for insulin-stimulated glucose...
Diabetes Mellitus: Overview and Type I Subtype
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Overview of Lipid Metabolism
Lipolysis: The Breakdown of Lipids:
Lipolysis is the process of breaking down lipids, particularly triglycerides, into glycerol and fatty acids. This process typically occurs in the adipose tissue and is triggered by various hormones, including glucagon and...
Diabetes: Management and Pharmacotherapy
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
